| Ritu M Kalwani, MD | |
|
2600 Greenbush St, Lafayette, IN 47904-2479 | |
| (765) 448-8000 | |
| (765) 448-7624 |
| Full Name | Ritu M Kalwani |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 2600 Greenbush St, Lafayette, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689643017 | NPI | - | NPPES |
| 9397198 | Other | IN | PHCS PID NUMBER |
| KA64890011 | Medicaid | IN | |
| 000000197893 | Other | IN | ANTHEM PROVIDER NUMBER |
| 100206600 | Medicaid | IN | |
| 10825352 | Other | IN | CAQH NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01035180A (Indiana) | Primary |
| Entity Name | Arnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
A multicenter group of 41 hospitals led by researchers at Children's Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the number of babies having invasive diagnostic examinations by nearly a third, while raising disease detection up to 100 percent.
Accurexa Inc., a biotechnology company focused on developing and commercializing novel neurological therapies, announced on Monday that it has filed a submission with the U.S. FDA for 510(k) clearance to market its BranchPoint device.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.
Vermont Gov. Peter Shumlin says the problems with the Affordable Care Act rollout are getting fixed – and that Republicans were boxing themselves in politically by focusing on failures instead of the successes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ritu M Kalwani, MD Po Box 5545, Lafayette, IN 47903-5545 Ph: (765) 448-8000 | Ritu M Kalwani, MD 2600 Greenbush St, Lafayette, IN 47904-2479 Ph: (765) 448-8000 |
News Archive
A multicenter group of 41 hospitals led by researchers at Children's Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the number of babies having invasive diagnostic examinations by nearly a third, while raising disease detection up to 100 percent.
Accurexa Inc., a biotechnology company focused on developing and commercializing novel neurological therapies, announced on Monday that it has filed a submission with the U.S. FDA for 510(k) clearance to market its BranchPoint device.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.
Vermont Gov. Peter Shumlin says the problems with the Affordable Care Act rollout are getting fixed – and that Republicans were boxing themselves in politically by focusing on failures instead of the successes.
› Verified 3 days ago
Michelle B Herberts, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-8564 | |
Dr. Carlos Salazar Carcamo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-583-2444 | |
Maria L Srour, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-448-7631 | |
Steven Rudolf Steinhubl, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5177 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-838-4333 | |
Michael Leo Hogan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3900 St Francis Way Ste 200, Lafayette, IN 47905 Phone: 765-775-2800 Fax: 765-775-2831 | |
Carlos A Gambirazio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7624 | |
Dr. Christopher Patrick Kaup, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Ferry St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-838-4698 |